Join our community of smart investors

Impax chiefs sell £1m in stock

Investors should not read too much into the fund house’s latest director trades
January 13, 2021
  • CEO and CFO cash out of 128,333 of shares
  • Disposals follow period of surging client flows

Investor flows to sustainable funds currently resemble a tidal wave. This week, the ESG-focused Liontrust Asset Management (LIO) said net client inflows hit £792m in the quarter to December. By Monday, the asset pile stood at £30.1bn, up 87 per cent since April.

Organic growth at Alternative Investment Market-listed peer Impax Asset Management (IPX) has been even better, having grown managed assets from £20.2bn to £25.2bn in the last three months of 2020.

Is this momentum itself sustainable? It is a question that Impax investors might have asked themselves this week, after chief executive Ian Simm and chief financial officer Charlie Ridge followed that trading update by selling 100,000 and 28,333 shares, respectively.

Though the disposals were “partly” to satisfy tax liabilities linked to share awards, they are not the first time the company’s top brass have sold into share price strength. In December, Mr Ridge made a separate sale of 66,666 shares at 710p a go, and was soon followed by Mr Simm, who cashed out of 20,000 shares, again in part to cover tax liabilities.

Nor are Impax’s directors alone in their disposals. On 25 November, with Liontrust's stock close to an all-time high after the publication of half-year numbers, the group's chief executive John Ions and chief operating officer Vinay Abrol both trimmed their holdings by 15,753 shares, each netting £223,223.

Investors feeling unnerved by this activity should maintain some perspective. Not only are these directors still heavily invested in both businesses – Messrs Ions and Abrol own a combined £29m of Liontrust stock, while Mr Simm’s stake exceeds £100m, per FactSet – but appetite for greener and more socially responsible businesses looks set to stay, even if some funds’ heavy weightings to tech stocks are a near-term vulnerability.

Though growth prospects remain strong for both, Impax shares look richly valued on 39 times forward earnings, versus a more reasonable 19 times for Liontrust - our current preference. Hold Impax at 853p.

Last IC view: Hold, 618p, 3 Dec 2020

Buys    
CompanyDirector/PDMRDatePrice (p)Aggregate value (£)
Benchmark HoldingsSeptima Maguire (cfo)5 Jan 216219,988
EnQuestFarina Khan11 Jan 2113.527,000
Euromoney Institutional InvestorColin Day7 Jan 211,08437,940
Pantheon InternationalJohn Burgess7 Jan 212,5153,849,987
River and MercantileJonathan Dawson (ch)11 Jan 2123423,400
Sells    
CompanyDirector/PDMRDatePrice (p)Aggregate value (£)
Andrew WrightJames Latham11 Jan 2192534,512
Berkeley Group HoldingsRobert Perrins (ce)8 Jan 214,74310,848,885
Impax Asset ManagementCharlie Ridge (cfo)5 Jan 21750212,498
Impax Asset ManagementIan Simm (ce)7 Jan 21840840,000
Randall & QuilterAlan Quilter (ce)6 Jan 21176704,000
YouGovJulien Chevignon8 Jan 211,040395,200
YouGovAndy Morris8 Jan 211,040400,400
YouGovDoug Rivers8 Jan 211,0402,600,000